Moshe Flashner-Barak
11Patents
4h-index
12Co-inventors
53Inventor score
Filing activity: Jan 26, 2001 → Jun 17, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8663703B2 | Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them | Performing Operations; Transporting | 63 | Active |
| US6881420B2 | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation | Human Necessities | 33 | Expired |
| US6476006B2 | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates | Human Necessities | 21 | Expired |
| US8188067B2 | Formulations of 6-mercaptopurine | Performing Operations; Transporting | 6 | Active |
| US8653060B2 | Formulations of 6-mercaptopurine | Performing Operations; Transporting | 4 | Active |
| US9375403B2 | Formulations of 6-mercaptopurine | Performing Operations; Transporting | 2 | Active |
| US9180097B2 | Formulations of 6-mercaptopurine | Performing Operations; Transporting | 2 | Active |
| US6569459B2 | Method of administration of paclitaxel-plasma protein formulation | Human Necessities | 1 | Expired |
| US9107832B2 | Risperidone microparticles formed by sublimation | Performing Operations; Transporting | 0 | Active |
| US7579333B2 | Therapy using a combination of raloxifene and alendronate | Human Necessities | 0 | Expired |
| US10525009B2 | Formulations of 6-mercaptopurine | Performing Operations; Transporting | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.